DrugsControl Media Services

News Detail

Roche questions Zydus on clinical trials for its breast cancer drug Perjeta (Pertuzumab) (01-02-2024)

Mumbai, 1 Feb 2024: Roche, the world's top seller of oncology drugs, has raised red flags against the clinical trials conducted by Indian drug maker Zydus Lifesciences on Perjeta (pertuzumab), its popular breast cancer treatment. The Swiss drug maker has alleged that 500 vials of......
View Details

Source : ET HealthWorld
roche zydus lifesciences cdsco perjeta pertuzumab dcgi clinical trials

Related News